Oncothyreon Inc. (Nasdaq: ONTY) announced that Merck KGaA, Darmstadt, Germany, has initiated the international Phase 3 START2 study, which is ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE